Mestag Therapeutics
Series AMestag Therapeutics is a privately held company based in United Kingdom, founded in 2020. The latest disclosed round is Series A ($40m), dated Mar 17, 2026. Institutional investors on record include Google Ventures.
United Kingdom · EST 2020
What is Mestag Therapeutics?
Mestag Therapeutics is a privately held company based in United Kingdom, founded in 2020. The latest disclosed round is Series A ($40m), dated Mar 17, 2026. Institutional investors on record include Google Ventures. Developer of therapeutics for the treatment of cancer and inflammatory diseases. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
Which funds backed Mestag Therapeutics?
Who invested in Mestag Therapeutics?
Funds on the dated round table. Open a name to read the fund card.
| Investor | Round | Amount | Date |
|---|---|---|---|
| Google Ventures | Series A | $40m | Mar 17, 2026 |
What do founders ask about Mestag Therapeutics?
What is Mestag Therapeutics?
Mestag Therapeutics is a privately held company based in United Kingdom, founded in 2020. The latest disclosed round is Series A ($40m), dated Mar 17, 2026. Institutional investors on record include Google Ventures. Developer of therapeutics for the treatment of cancer and inflammatory diseases. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
What was Mestag Therapeutics's last funding round?
Mestag Therapeutics's latest disclosed round is Series A at $40m (Mar 17, 2026).
Who invested in Mestag Therapeutics?
Mestag Therapeutics has 1 institutional investors on this page, including Google Ventures.
How does CrackTheDeck cover Mestag Therapeutics?
This startup card lists dated rounds and linked fund profiles so founders can see who is already in the cap table before a pitch.
How is this page compiled?
Round, amount, and investor names on the Mestag Therapeutics card come from dated financings linked to fund profiles in CrackTheDeck. Empty fields mean the figure was not in those records. Updated Aug 2026.